Full Text of HR0193 102nd General Assembly
HR0193 102ND GENERAL ASSEMBLY |
| | HR0193 | | LRB102 17559 MST 23221 r |
|
| 1 | | HOUSE RESOLUTION
| 2 | | WHEREAS, Many peoples with serious, chronic mental | 3 | | illness, such as schizophrenia, bipolar disorder, severe | 4 | | depression, or gastrointestinal disorders that include | 5 | | gastroparesis, nausea, and vomiting, require treatment with | 6 | | medications that work as dopamine receptor blocking agents | 7 | | (DRBAs), including antipsychotics; and
| 8 | | WHEREAS, While ongoing treatment with these medications | 9 | | can be very helpful, even lifesaving, for many people, it can | 10 | | also lead to Tardive Dyskinesia (TD); and | 11 | | WHEREAS, Tardive Dyskinesia is a movement disorder that is | 12 | | characterized by random, involuntary, and uncontrolled | 13 | | movements of different muscles in the face, trunk, and | 14 | | extremities; and | 15 | | WHEREAS, Tardive Dyskinesia can develop months, years, or | 16 | | decades after a person starts taking DRBAs and even after they | 17 | | have discontinued use of those medications; not everyone who | 18 | | takes a DRBA develops TD, but if it develops, it is often | 19 | | permanent; and
| 20 | | WHEREAS, It is estimated that over 500,000 Americans | 21 | | suffer from Tardive Dyskinesia; according to the National |
| | | HR0193 | - 2 - | LRB102 17559 MST 23221 r |
|
| 1 | | Alliance for Mental Illness, one in every four patients | 2 | | receiving long-term treatment with an antipsychotic medication | 3 | | will experience Tardive Dyskinesia; and
| 4 | | WHEREAS, Years of difficult and challenging research have | 5 | | resulted in recent scientific breakthroughs, with two new | 6 | | treatments for Tardive Dyskinesia approved by the United | 7 | | States Food and Drug Administration; and
| 8 | | WHEREAS, Tardive Dyskinesia is often unrecognized, and | 9 | | patients suffering from the illness are commonly misdiagnosed; | 10 | | regular screening for TD in patients taking DRBA medications | 11 | | is recommended by the American Psychiatric Association (APA); | 12 | | therefore, be it
| 13 | | RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE | 14 | | HUNDRED SECOND GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that | 15 | | we declare the week of May 2, 2021 as "Tardive Dyskinesia | 16 | | Awareness Week" in the State of Illinois; and be it further
| 17 | | RESOLVED, That we encourage every individual in the United | 18 | | States to become better informed about and aware of Tardive | 19 | | Dyskinesia.
|
|